RecruitingNot ApplicableNCT07458802

Healthy Expectancy Through Routine Antenatal STI Screening

Screening and Treatment for Chlamydia Trachomatis Infection to Prevent Preterm Birth


Sponsor

Adriane Wynn

Enrollment

2,000 participants

Start Date

May 25, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate whether routine screening and treatment for two common sexually transmitted infections, chlamydia and gonorrhoea, during pregnancy can reduce preterm birth and other poor birth outcomes in Botswana, and whether this approach is affordable and cost-effective for the health system. About 2,000 pregnant women attending their first antenatal care visit at up to 10 government clinics in Botswana will be invited to join the study. All women will first receive the usual antenatal care services provided in Botswana, including routine health checks and HIV and syphilis testing. Women who enroll in the study will be randomly assigned to one of two groups: 1. Standard of care group: Women receive routine antenatal care only. 2. Intervention group: In addition to routine antenatal care, women are screened for chlamydia and gonorrhoea using self-collected vaginal swabs at their first antenatal care visit and again in the third trimester. The main outcome of the study is whether screening and treating chlamydia and gonorrhoeae reduces preterm birth (before 37 weeks). Other outcomes include low birth weight, very preterm birth, and maternal health conditions.


Eligibility

Sex: FEMALEMin Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Chlamydia trachomatis and Neisseria gonorrhoeae screening for people with chlamydia, chlamydia trachomatis, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTChlamydia trachomatis and Neisseria gonorrhoeae screening

Screening with Xpert® CT/NG assay at first antenatal care and third trimester


Locations(1)

Botswana Harvard Health Partnership

Gaborone, Botswana

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07458802


Related Trials